Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinoma
Advanced renal cell carcinoma is a biologically heterogeneous disease with multiple treatment options that largely involve immunotherapy and/or anti-angiogenic therapies. The choice of initial and subsequent therapy depends on both clinical and biological considerations. Here, we describe the applic...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-03-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/11/3/e006361.full |
| _version_ | 1797871788516966400 |
|---|---|
| author | James Brugarolas Michael B Atkins Brian I Rini |
| author_facet | James Brugarolas Michael B Atkins Brian I Rini |
| author_sort | James Brugarolas |
| collection | DOAJ |
| description | Advanced renal cell carcinoma is a biologically heterogeneous disease with multiple treatment options that largely involve immunotherapy and/or anti-angiogenic therapies. The choice of initial and subsequent therapy depends on both clinical and biological considerations. Here, we describe the application of recent data to clinical practice. |
| first_indexed | 2024-04-10T00:49:39Z |
| format | Article |
| id | doaj.art-4cba60273fac488aabdf0ef591f21807 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-04-10T00:49:39Z |
| publishDate | 2023-03-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-4cba60273fac488aabdf0ef591f218072023-03-13T16:00:10ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-03-0111310.1136/jitc-2022-006361Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinomaJames Brugarolas0Michael B Atkins1Brian I Rini2Aff2 0000 0000 9482 7121grid.267313.2Kidney Cancer Program, Department of Internal Medicine, Harold C. Simmons Comprehensive Cancer CenterUniversity of Texas Southwestern Medical Center Dallas Texas USAGeorgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USAAff9 0000 0001 0675 4725grid.239578.2Lerner College of Medicine, Department of Hematology and OncologyCleveland Clinic Taussig Cancer Institute 44195 Cleveland OH USAAdvanced renal cell carcinoma is a biologically heterogeneous disease with multiple treatment options that largely involve immunotherapy and/or anti-angiogenic therapies. The choice of initial and subsequent therapy depends on both clinical and biological considerations. Here, we describe the application of recent data to clinical practice.https://jitc.bmj.com/content/11/3/e006361.full |
| spellingShingle | James Brugarolas Michael B Atkins Brian I Rini Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinoma Journal for ImmunoTherapy of Cancer |
| title | Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinoma |
| title_full | Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinoma |
| title_fullStr | Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinoma |
| title_full_unstemmed | Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinoma |
| title_short | Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinoma |
| title_sort | navigating and adapting care integrating immunotherapy antiangiogenic therapy and combinations in patients with advanced renal cell carcinoma |
| url | https://jitc.bmj.com/content/11/3/e006361.full |
| work_keys_str_mv | AT jamesbrugarolas navigatingandadaptingcareintegratingimmunotherapyantiangiogenictherapyandcombinationsinpatientswithadvancedrenalcellcarcinoma AT michaelbatkins navigatingandadaptingcareintegratingimmunotherapyantiangiogenictherapyandcombinationsinpatientswithadvancedrenalcellcarcinoma AT brianirini navigatingandadaptingcareintegratingimmunotherapyantiangiogenictherapyandcombinationsinpatientswithadvancedrenalcellcarcinoma |